本文選題：慢性心力衰竭　切入點(diǎn)：心肺功能　出處：《遼寧中醫(yī)藥大學(xué)》2017年碩士論文

【摘要】：目的:觀察常規(guī)藥物治療聯(lián)合太極拳運(yùn)動(dòng)對(duì)慢性心力衰竭患者心肺功能參數(shù)、NT-pro BNP、左室射血分?jǐn)?shù)的作用,以及對(duì)明尼蘇達(dá)心衰生活質(zhì)量評(píng)分的影響,探討太極拳運(yùn)動(dòng)在慢性心力衰竭患者康復(fù)治療中的作用。資料與方法:選取2015年6月至2016年4月于遼寧省人民醫(yī)院心內(nèi)科住院治療的慢性心力衰竭(心功能II-III級(jí))患者60例,男31例,女29例,平均年齡61.2±6.1(50-70)歲,按隨機(jī)數(shù)字表隨機(jī)分為常規(guī)治療組(對(duì)照組)和太極拳組(試驗(yàn)組),兩組根據(jù)《2016ESC急慢性心力衰竭診斷和治療指南》進(jìn)行診斷及治療,采用美國(guó)紐約心臟病學(xué)會(huì)的心功能分級(jí)標(biāo)準(zhǔn)進(jìn)行分級(jí)。對(duì)照組依據(jù)上述指南進(jìn)行常規(guī)藥物治療,太極拳組在常規(guī)藥物治療基礎(chǔ)上增加6個(gè)月的24式太極拳鍛煉,每周鍛煉3-5次,每次30min。記錄年齡、性別、身高、體重、BMI、血壓等一般情況以及治療前后心肺功能參數(shù)、NT-pro BNP、左室射血分?jǐn)?shù)(LVEF)以及明尼蘇達(dá)心衰生活質(zhì)量評(píng)分,并進(jìn)行比較。結(jié)果:1.心肺功能指標(biāo):治療前常規(guī)治療組與太極拳組無(wú)氧閾值(AT)、峰值攝氧量(VO2max)、氧脈比(AT:9.08±0.53ml/kg.min vs.8.96±0.49ml/kg.min,P0.05;VO2max:14.55±1.04 ml/kg.min vs.14.66±1.05ml/kg.min,P0.05;氧脈比:8.40±0.47 ml/bpm vs.8.57±0.52ml/bpm,P0.05)無(wú)顯著性差異;治療后常規(guī)治療組與太極拳組AT、VO2max及氧脈比(AT:9.57±0.63ml/kg.min vs.10.38±0.48ml/kg.min,P0.05;VO2max:15.49±0.87ml/kg.min vs.16.72±1.05ml/kg.min,P0.05;氧脈比:9.48±0.52ml/bpm vs.10.25±1.23ml/bpm,P0.05)均升高,與常規(guī)治療組相比,太極拳組升高更顯著;治療前后常規(guī)治療組與太極拳組AT、VO2max、氧脈比(AT:9.08±0.53ml/kg.min vs.9.57±0.63ml/kg.min,8.96±0.49ml/kg.min vs.10.38±0.48ml/kg.min,P0.05);VO2max:14.55±1.04 ml/kg.min vs.15.49±0.87ml/kg.min,14.66±1.05ml/kg.min vs.16.72±1.05ml/kg.min,P0.05;氧脈比:8.40±0.47 ml/bpm vs.9.48±0.52ml/bpm,8.57±0.52ml/bpm vs.10.25±1.23ml/bpm,P0.05)比較有統(tǒng)計(jì)學(xué)差異。2.NT-pro BNP:治療前常規(guī)治療組與太極拳組NT-pro BNP值(435.9±199.7ng/l vs.415.0±240.8ng/l,P0.05)比較無(wú)統(tǒng)計(jì)學(xué)差異;治療后常規(guī)治療組與太極拳組NT-pro BNP值均下降(338.9±213.6ng/l vs.203.1±231.6ng/l,P0.05),與常規(guī)治療組相比,太極拳組降低更顯著;治療前后常規(guī)治療組與太極拳組NT-pro BNP值(435.9±199.7ng/l vs.338.9±213.6ng/l,415.0±240.8ng/l vs.203.1±231.6ng/l,P0.05)比較有統(tǒng)計(jì)學(xué)差異。3.左室射血分?jǐn)?shù):治療前常規(guī)治療組與太極拳組LVEF值(0.42±0.06 vs.0.40±0.07,P0.05)比較無(wú)統(tǒng)計(jì)學(xué)差異;治療后常規(guī)治療組與太極拳組LVEF值(0.44±0.08vs.0.42±0.03,P0.05)均升高,但無(wú)統(tǒng)計(jì)學(xué)差異;治療前后常規(guī)治療組與太極拳組LVEF值(0.42±0.06 vs.0.44±0.08,0.40±0.07 vs.0.42±0.03,P0.05)比較亦無(wú)統(tǒng)計(jì)學(xué)差異。4.明尼蘇達(dá)心衰生活質(zhì)量評(píng)分表:治療前常規(guī)治療組與太極拳組評(píng)分(43.39±9.18vs.46.66±10.94,P0.05)比較無(wú)統(tǒng)計(jì)學(xué)差異;治療后常規(guī)治療組與太極拳組評(píng)分均降低(33.96±9.58 vs.25.22±6.97,P0.05),與常規(guī)治療組相比,太極拳組降低更顯著;治療前后常規(guī)治療組與太極拳組評(píng)分(43.39±9.18 vs.33.96±9.58,46.66±10.94vs.25.22±6.97,P0.05)有統(tǒng)計(jì)學(xué)差異。結(jié)論:1.藥物聯(lián)合太極拳運(yùn)動(dòng),能進(jìn)一步的提高慢性心力衰竭患者的無(wú)氧閾值、峰值攝氧量和氧脈比,降低NT-pro BNP水平。2.通過(guò)藥物聯(lián)合太極拳運(yùn)動(dòng)能更好的改善慢性心力衰竭患者的運(yùn)動(dòng)耐量,提高患者的生存質(zhì)量。3.心肺功能指標(biāo)能準(zhǔn)確客觀的評(píng)價(jià)慢性心力衰竭患者的狀況。
[Abstract]:Objective: To observe the routine drug therapy combined with Taijiquan exercise parameters on cardiopulmonary function in patients with chronic heart failure NT-pro BNP, left ventricular ejection fraction, and the influence on the quality of life score of heart failure in Minnesota, to explore the Taijiquan exercise rehabilitation in patients with chronic heart failure Kang. Materials and methods: from June 2015 to April 2016 Liaoning Provincial People's Hospital Department of Cardiology hospitalized chronic heart failure (NYHA class II-III) 60 cases, male 31 cases, female 29 cases, mean age 61.2 + 6.1 (50-70) years old, were randomly divided into routine treatment group (control group) and Taijiquan group (experimental group), two groups according to the <2016ESC "guidelines for diagnosis and treatment of chronic heart failure diagnosis and treatment, the New York Heart Association standard classification of cardiac function classification. The control group on the basis of the above guidelines for routine drug treatment The Tai Chi Group, an increase of 24 Style Taijiquan exercise for 6 months on the basis of conventional drug treatment, exercise 3-5 times a week, every time 30min. record the age, gender, height, weight, BMI, blood pressure and other general situation before and after the treatment of heart and lung function parameters, NT-pro BNP, left ventricular ejection fraction (LVEF) and the quality of life of Minnesota heart failure score, and compared. Results: 1. heart lung function index: before treatment, the conventional treatment group and Taijiquan group anaerobic threshold (AT), peak oxygen uptake (VO2max), oxygen pulse ratio (AT:9.08 + 0.53ml/kg.min vs.8.96 + 0.49ml/kg.min, P0.05 + 1.04 ml/kg.min vs.14.66 + VO2max:14.55; 1.05ml/kg.min, P0.05; oxygen pulse ratio: 8.40 + 0.47 ml/bpm vs.8.57 + 0.52ml/bpm, P0.05) had no significant difference; after treatment, routine treatment group and Taijiquan group AT, VO2max and oxygen pulse ratio (AT:9.57 + 0.63ml/kg.min vs.10.38 + 0.48ml/kg.min, VO2max:15.49 + 0.87ml/kg.min vs.1 P0.05; 6.72 + 1.05ml/kg.min, P0.05; oxygen pulse ratio: 9.48 + 0.52ml/bpm vs.10.25 + 1.23ml/bpm, P0.05) were increased, compared with the conventional treatment group, Taiji group increased more significantly after treatment; the routine treatment group and Taijiquan group AT, VO2max, oxygen pulse ratio (AT:9.08 + 0.53ml/kg.min vs.9.57 + 0.63ml/kg.min, 8.96 + 0.49ml/kg.min + vs.10.38 0.48ml/kg.min, P0.05); VO2max:14.55 + 1.04 ml/kg.min vs.15.49 + 0.87ml/kg.min, 14.66 + 1.05ml/kg.min vs.16.72 + 1.05ml/kg.min, P0.05; oxygen pulse ratio: 8.40 + 0.47 ml/bpm vs.9.48 + 0.52ml/bpm, 8.57 + 0.52ml/bpm vs.10.25 + 1.23ml/bpm, P0.05) were statistically significant difference.2.NT-pro BNP: before treatment, routine treatment group and Taijiquan group NT-pro BNP value (435.9. 199.7ng/l vs.415.0 + 240.8ng/l, P0.05) showed no significant difference; after treatment, routine treatment group and Taijiquan group NT-pro BNP decreased (338.9 + 213.6ng/l + 231 vs.203.1 .6ng/l, P0.05), compared with the conventional treatment group, Taiji group decreased more significantly; the routine treatment group and Taijiquan group NT-pro BNP value before and after treatment (435.9 + 199.7ng/l vs.338.9 415 + 240.8ng/l + 213.6ng/l, vs.203.1 + 231.6ng/l, P0.05) compared with left ventricular ejection fraction:.3. significant difference before treatment and treatment group the Tai Chi Group LVEF (0.42 + 0.06 vs.0.40 + 0.07, P0.05) showed no significant difference; the routine treatment group and Taijiquan group LVEF value after treatment (0.44 + 0.08vs.0.42 + 0.03, P0.05) were increased, but the difference was not statistically significant; the routine treatment group and Taijiquan group LVEF values before and after treatment (0.42 + 0.06 vs.0.44 + 0.08,0.40 + 0.07 vs.0.42 + 0.03, P0.05) is also no significant difference in the.4. Minnesota heart failure quality of life scale: before treatment, the conventional treatment group and Taijiquan group score (43.39 + 9.18vs.46.66 + 10.94, P0.05) and there was no significant difference in treatment; After conventional treatment group and Taijiquan group were significantly reduced (33.96 + 9.58 vs.25.22 + 6.97, P0.05), compared with the conventional treatment group, Taiji group decreased more significantly after treatment; the routine treatment group and Taijiquan group score (43.39 + 9.18 vs.33.96 + 9.58,46.66 + 10.94vs.25.22 + 6.97, P0.05). Conclusion there is significant difference 1. drugs combined with Taijiquan exercise, can further improve the anaerobic threshold in patients with chronic heart failure, peak oxygen uptake and oxygen pulse ratio, reduce the NT-pro level of BNP.2. can better through drugs combined with Taijiquan exercise to improve exercise tolerance in patients with chronic heart failure, improve the quality of life of.3. heart and lung function indices in patients with accurate and objective the evaluation of patients with chronic heart failure.

【學(xué)位授予單位】：遼寧中醫(yī)藥大學(xué)
【學(xué)位級(jí)別】：碩士
【學(xué)位授予年份】：2017
【分類(lèi)號(hào)】：R541.6

【參考文獻(xiàn)】

相關(guān)期刊論文 前10條

1 程遠(yuǎn)玲;趙藝尋;隋晶晶;胡延平;;抑郁、焦慮在老年科冠心病心衰患者中發(fā)生率及其影響因素[J];國(guó)際精神病學(xué)雜志;2016年05期

2 陳偉偉;高潤(rùn)霖;劉力生;朱曼璐;王文;王擁軍;吳兆蘇;李惠君;顧東風(fēng);楊躍進(jìn);鄭哲;蔣立新;胡盛壽;;《中國(guó)心血管病報(bào)告2015》概要[J];中國(guó)循環(huán)雜志;2016年06期

3 劉亮;;太極拳聯(lián)合運(yùn)動(dòng)康復(fù)訓(xùn)練治療老年冠心病的療效及對(duì)不良心理和生活質(zhì)量的影響[J];中西醫(yī)結(jié)合心腦血管病雜志;2016年05期

4 隋朔;梁曉光;;穩(wěn)定性慢性心衰患者康復(fù)運(yùn)動(dòng)的療效觀察[J];中國(guó)實(shí)用醫(yī)藥;2016年01期

5 周京敏;崔曉通;葛均波;;中國(guó)心力衰竭的流行病學(xué)概況[J];中華心血管病雜志;2015年12期

6 舒華;張世鷹;王笑瑩;吳治諺;陳青揚(yáng);蔡虎志;陳新宇;;“動(dòng)而生陽(yáng)”理論對(duì)慢性心力衰竭患者運(yùn)動(dòng)康復(fù)影響分析[J];湖南中醫(yī)藥大學(xué)學(xué)報(bào);2015年11期

7 于靜;;中醫(yī)健身操對(duì)慢性心力衰竭患者運(yùn)動(dòng)耐力影響的研究[J];中國(guó)中醫(yī)藥現(xiàn)代遠(yuǎn)程教育;2015年21期

8 辛哲;;健身氣功八段錦歷史發(fā)展的審視及其價(jià)值實(shí)現(xiàn)路徑選擇[J];沈陽(yáng)體育學(xué)院學(xué)報(bào);2015年04期

9 胡利勛;楊建全;;健步走聯(lián)合太極拳對(duì)老年高血壓患者血壓、血糖和血脂的影響[J];海南醫(yī)學(xué);2015年14期

10 桑林;劉卓;郎芳;田瑗;張洪俠;;“太極康復(fù)操”對(duì)老年冠心病慢性心衰患者心臟功能及生活質(zhì)量的影響[J];中國(guó)老年學(xué)雜志;2015年14期

相關(guān)博士學(xué)位論文 前1條

1 賴(lài)少偉（Lai Siu Wai）;慢性心力衰竭患者中醫(yī)運(yùn)動(dòng)養(yǎng)生的現(xiàn)況研究[D];廣州中醫(yī)藥大學(xué);2014年

相關(guān)碩士學(xué)位論文 前1條

1 黃超;太極抱球云手對(duì)冠心病慢性心力衰竭（NYHA Ⅲ級(jí)）患者心功能康復(fù)的研究[D];福建中醫(yī)藥大學(xué);2014年

，

本文編號(hào)：1729564